# Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

> **NCT03159143** · PHASE2 · COMPLETED · sponsor: **Leonard Appleman** · enrollment: 22 (actual)

## Conditions studied

- Metastatic Transitional Cell Cancer of the Urothelial Tract

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT03159143
- **Lead sponsor:** Leonard Appleman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-17
- **Primary completion:** 2009-06-02
- **Final completion:** 2009-12-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159143, "Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03159143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*